Gilead Sciences
United StatesFounded 198715,002+ employeesGILD
$4.4B raisedIPO· last: post ipo debt (Nov 2024)· 5 rounds
Backed by(2 investors)
Abingworth · Lead+1 more
7 layoff events · Last: May 2026
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
